Misoprostol como método para la inducción del parto en pacientes primigestas atendidas en el Hospital General Guasmo Sur periodo 2020- 2023.

Abstract

Misoprostol is a synthetic analogue of prostaglandin E1, which has been widely used in obstetrics as a method for cervical ripening during induction of preterm labor. Objective: To assess the usefulness of misoprostol as a method of labor induction in preterm patients attended at the Hospital General Guasmo Sur in the period 2020-2023. Methodology: A descriptive observational study was carried out to confirm the benefit of using misoprostol as a method for labor induction in primigravid patients attended at the Hospital General Guasmo Sur during the period 2020-2023. Results: This study included 134 primigravid patients in whom misoprostol was administered for labor induction. The most common gestational age at which induction of labor was performed was 38 to 38.6 weeks of gestation, which corresponds to 31.34%. Of the total number of princesses whose labor was induced, 55.97% terminated the pregnancy vaginally and 44.03% terminated the pregnancy by cesarean section. In addition, 52.99% of the patients who were induced received misoprostol vaginally. Among the indications for induction of labor the most frequent was prolonged latent phase with 32.09%. Conclusions: We found that induction of labor with misoprostol was effective in 55.97% of pregnant women culminating their pregnancy vaginally. Finally, we observed that among the indications for induction of labor, the most predominant was prolonged latent phase with 32.09%, followed by premature rupture of membranes with 29.10%.